Useful Management Information

The Aridol Challenge assesses bronchial hyperresponsiveness (an abnormal increase in airflow limitation following exposure to a non-allergic stimulus) to Mannitol. Although bronchial hyperresponsiveness is not specific for asthma, nearly all patients with asthma exhibit increased bronchial hyperresponsiveness.

Indication:

  • For identifying bronchial hyperresponsiveness to assist in the diagnosis of asthma.
  • The following may pose a relative danger to the patient or affect the validity of the test:
    • A resting FEV1 of <70% predicted or in adults an absolute value of <1.5L.
    • Spirometry induced bronchoconstriction.
    • Inability to perform spirometry of acceptable quality.
    • Upper or lower respiratory tract infection in the previous 2 weeks.
    • Aridol should not be given to pregnant women.
    • Caution should be exercised when mannitol is administered to breastfeeding women
    • The test should not be performed in patients below 6 years of age.
    • Requires withholding of respiratory medications prior to the test.
    • Acute myocardial infarction within 1 week.
    • Systemic hypotension or severe hypertension.
    • Significant atrial/ventricular arrhythmia.
    • Non-compensated heart failure.
    • Uncontrolled pulmonary hypertension.
    • Acute cor pulmonale.
    • Clinically unstable pulmonary embolism.
    • History of syncope related to forced expiration/cough.
    • Cerebral aneurysm.
    • Brain surgery within 4 weeks.
    • Recent concussion with continuing symptoms.
    • Eye surgery within 1 week.
    • Sinus surgery or middle ear surgery or infection within 1 week.
    • Presence of pneumothorax.
    • Thoracic surgery within 4 weeks.
    • Abdominal surgery within 4 weeks.
    • Active or suspected transmissible respiratory or systemic infection including tuberculosis.
    • Physical conditions predisposing to transmission of infections.

Minimum Referral Criteria

Does your patient meet the minimum referral criteria?
Category Category 1 ((appointment within 30 calendar days))
  • Requires tests within 30 days.
Category Category 2 ((appointment within 90 calendar days))
  • Requires tests within 90 calendar days
Category Category 3 ((appointment within 365 calendar days))
  • Requires tests within 365 days.

Essential Referral Information

This must be contained in the referral for it to be accepted.

  • This test requires respiratory physician approval and a signed ‘Bronchoprovocation test’ consent form.
  • Reason for referral - what is the clinical question to be answered by performing the test?
  • Current respiratory medications
  • Infectious status

If a specific test result is unable to be obtained due to access, financial, religious, cultural or consent reasons a Clinical Override may be requested. This reason must be clearly articulated in the body of the referral.

Additional Referral Information

  • No additional referral information
Last updated 5 August 2021

Send Referrals To

Smart Referrals

Not Available

Secure Web Transfer

Not Available

Internal Referrals

Lung Function Lab (E-Blueslips)

Fax

(07) 5687 4497

Post

Lung Function Lab
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

1300 744 284

Related HealthPathways

No directly related pathways found

Service Availability

Dr Carl Pahoff
Medical Director Respiratory - Lung Function Laboratory, and Pulmonary Function Tests

Facilities

Gold Coast University Hospital
Robina Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.